Comparison of perinatal outcome between ICP and chronic hepatitis B with elevated ser-um total bile acid during pregnancy

Jielian Yang,Min Liu
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2017.10.006
2017-01-01
Abstract:Objective:To explore the differences of biochemical indicators and preg-nancy outcomes between ICP and chronic hepatitis B with elevated serum total bile acid during pregnancy . Methods:A retrospective analysis of patients was performed on the data of 262 preg-nant women who had their prenatal examinations and delivered in Shanghai Public Health Clini-cal Center from Dec. 2013 to Nov. 2015. They were divided into two groups:intrahepatic chole-stasis of pregnancy group ( ICP) (116 cases) ,and chronic hepatitis B group ( CHB) with ele-vated serum total bile acid( TBA) (146 cases) . Results:No significant difference was found in the liver function indicators between the two groups when the TBA was in the peak level. After treatment,TBA and transaminase significantly decreased in both groups. The level of transami-nase in ICP group was still higher than that of CHB group(P<0. 05). The rate of fetal distress, meconium stained amniotic fluid( MSAF) ,incidence of premature delivery,asphyxia of newborn ( Apgar score in 1 and 5 minute) had statistically significant difference between the two groups (P<0. 05). In ICP group,the rate of LGA was significantly higher than that of CHB group ( 9 . 84% vs 2 . 1%) . Conclusions:ICP and pregnancy with CHB will be significantly improved after active treatment. In the disease observation of simple ICP,both bile acid and transaminases levels should be paid high attention. In CHB pregnant women, if there is a good treatment effect,the gestational age can be extended under closely monitoring.
What problem does this paper attempt to address?